<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=Lentivirus_pseudovirus</id>
	<title>Lentivirus pseudovirus - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=Lentivirus_pseudovirus"/>
	<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=Lentivirus_pseudovirus&amp;action=history"/>
	<updated>2026-10-18T10:34:48Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://eln.excellgen.com/index.php?title=Lentivirus_pseudovirus&amp;diff=21413&amp;oldid=prev</id>
		<title>Paul.xu at 18:31, 6 March 2021</title>
		<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=Lentivirus_pseudovirus&amp;diff=21413&amp;oldid=prev"/>
		<updated>2021-03-06T18:31:47Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;packaging Plasmids:&lt;br /&gt;
&lt;br /&gt;
psPAX2 503, --&amp;gt;Gag, Pol&amp;amp;nbsp;https://cdn.cellecta.com/Cellecta-psPAX2-in-CPCP-K2A-Map.pdf&lt;br /&gt;
&lt;br /&gt;
pCMV-VSVG, pMD2.G, 505--&amp;gt;VSVG&amp;amp;nbsp;https://cdn.cellecta.com/Cellecta-pMD2.G-in-CPCP-K2A-Map.pdf&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
do not know if pRSV-Rev 504 is required&lt;br /&gt;
&lt;br /&gt;
[https://manuals.cellecta.com/lentiviral-construct-packaging-and-transduction/v10a/en/topic/lentiviral-packaging-protocol https://manuals.cellecta.com/lentiviral-construct-packaging-and-transduction/v10a/en/topic/lentiviral-packaging-protocol]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830501/&lt;br /&gt;
The lentiviral transfer vector DNA, together with psPAX2 packaging and pMD2. G envelope plasmid DNA were combined at a ratio of 4:3:1, respectively. Production of 3rd generation lentivirus was performed using the combined ratio of transfer plasmid, packaging plasmid, Env plasmid and pRSV-Rev plasmid at 4:2:1:1,&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Acrodisc purification&lt;br /&gt;
Purification of lentivirus using a Mustang Q Acrodisc (PALL) was performed according to the manufacturer’s recommendations. Briefly, 50 mL aliquots of lentivirus supernatant were adjusted to 25 mM Tris-HCl, pH 8.9 and loaded onto a Mustang Q Acrodisc and filtered through the Acrodisc syringe filter. The Acrodisc was eluted using a step gradient ranging from 0.3 to 1.5 M NaCl in 25 mM Tris-HCl, pH 8.5. Filtered supernatant was then added to 36 mL pollyallomer conical tubes and ultracentrifuged at 20,000 g for 90 min.&lt;br /&gt;
&lt;br /&gt;
Optiprep purification&lt;br /&gt;
For concentration using Optiprep (Axis-shield), a 220 μL cushion of Optiprep was added to pollyallomer conical tubes and lentivirus-containing supernatant (30 mL) was gently layered into each tube taking care not to disturb the Optiprep. Samples were ultracentrifuged at 20,000 g for 90 min. Media above the media/Optiprep interface was carefully removed from each tube and discarded. The residual media containing lentivirus and Opitiprep was shaken at 200 rpm for 2 hrs in sealed tubes. The resulting mixture was pooled and centrifuged at 20,000 g for 24 hrs. Supernatant was discarded and the remaining pellet was resuspended in 300 μL of PBS, shaken overnight at 4°C, and then stored at -80°C until use.&lt;br /&gt;
[[Category:Virus]]&lt;/div&gt;</summary>
		<author><name>Paul.xu</name></author>
	</entry>
</feed>